Reinventing the fight against bacteria, one phage at a time.

Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission WINNIPEG, September 29, 2025 — Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV: CYTO, FSE: 70G) announced its participation in the Canadian biomanufacturing mission held in Lyon and Paris, France from September 21-25, 2025 under the Canadian International Innovation Program (CIIP). This government-led initiative, organized by Global Affairs Canada and the National Research Council of Canada, brought together leading Canadian companies to explore co-innovation opportunities within the French bioeconomy. “We engaged with prospective European partners on this mission to help advance the commercialization of our bacteriophage products globally,” said Dr. Steven Theriault, CEO of Cytophage. “We were honoured to represent Canadian innovation alongside our esteemed industry peers, and grateful for the federal government’s support for this mission. We extend our sincere th...

How bacteria 'vaccinate' themselves with genetic material from dormant viruses Summary: Scientists say they have shed new light on how bacteria protect themselves from certain phage invaders -- by seizing genetic material from weakened, dormant phages and using it to 'vaccinate' themselves to elicit an immune response. Like people, bacteria get invaded by viruses. In bacteria, the viral invaders are called bacteriophages, derived from the Greek word for bacteria-eaters, or in shortened form, "phages." Scientists have sought to learn how the single-cell organisms survive phage infection in a bid to further understand human immunity and develop ways to combat diseases. Now, Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage invaders -- by seizing genetic material from weakened, dormant phages and using it to "vaccinate" themselves to elicit an immune response. In their experiments, the s...